Nivolumab Injection

Nivolumab Injection

10000 INR/Piece

Product Details:

  • Physical Color/Texture Injection
  • Storage Instructions Keep dry & cool place
  • Shelf Life 2 Years
  • Click to view more

Nivolumab Injection Price And Quantity

  • 10 Piece
  • 10000 INR/Piece

Nivolumab Injection Product Specifications

  • Keep dry & cool place
  • Injection
  • 2 Years

Nivolumab Injection Trade Information

  • 1 Week
  • Asia Australia Central America North America South America Eastern Europe Western Europe Middle East Africa
  • All India

Product Description

A drug called nivolumab injection is used in cancer immunotherapy. It is a monoclonal antibody that targets the programmed cell death protein 1 (PD-1) receptor on T cells and is a member of the class of immune checkpoint inhibitors. Nivolumab improves the immune system's capacity to identify and combat cancer cells by inhibiting this receptor. It is used to treat a number of advanced or metastatic tumours, including Hodgkin lymphoma, non-small cell lung cancer, melanoma, and renal cell carcinoma. In some individuals, nivolumab has showed promise in increasing long-term remission rates and overall survival. However, it may result in immune-related adverse effects, such as tiredness, rash, and organ inflammation, which call for close observation and management by medical professionals. 


 Benefits and Characteristics of Nivolumab Injection


1. Nivolumab, an immune checkpoint inhibitor, specifically targets the T cell's PD-1/programmed cell death protein 1 (PD-1) receptor.

2. It is a monoclonal antibody that is made to bind to and recognise PD-1, preventing it from interacting with cancer cells.

3. Nivolumab, a specific target of targeted immunotherapy, strengthens the immune system's capacity to identify and combat cancer cells.

4. Multiple Cancer Types: It is used to treat a number of advanced or metastatic malignancies, including Hodgkin lymphoma, non-small cell lung cancer, melanoma, and renal cell carcinoma.

5. Nivolumab is given intravenously to achieve systemic administration, which enables it to circulate throughout the body and target cancer cells in various locations.


1. Survival Rates Have Increased: Nivolumab has showed promise in raising survival rates overall and extending progression-free survival in select cancer patients.

2. Long-Term Remission: In certain patients, it may result in long-lasting remissions, improving illness management.

3. Reduced Toxicity: Nivolumab is thought to cause less toxicity than conventional chemotherapy, which helps people tolerate treatment better and live healthier lives.

4. Nivolumab offers a personalised method of treating cancer that is adapted to the patient's unique immune response and tumour features.

5. It has the potential to be used in conjunction with other cancer therapies to boost efficacy and provide synergistic effects.

6. Nivolumab has demonstrated effectiveness in treating malignancies that have grown resistant to other treatments.

7. Durability of Response: Nivolumab medication has occasionally shown persistent responses, resulting in long-lasting remissions and disease control.

8. Nivolumab has increased the therapy options available to patients with metastatic or advanced malignancies, raising the prospect of a better prognosis.

9. Promising Research: Nivolumab's potential for treating different cancer types is still being investigated in ongoing clinical trials and research, which is advancing cancer immunotherapy.

While Nivolumab Injection has a lot to give in the fight against cancer, it can also have immune-related side effects like weariness, rash, and organ inflammation that need to be well watched and managed by medical professionals. Nivolumab should only ever be used under the guidance of a skilled oncologist or immunotherapy specialist.

 Nivolumab Injection Applications:

1. Melanoma: Patients with advanced melanoma, a form of skin cancer, who have not responded to conventional therapies are treated with nivolumab.

2. Non-Small Cell Lung Cancer (NSCLC): After first-line chemotherapy, it is used to treat metastatic NSCLC that has advanced.

3. Renal Cell Carcinoma: Patients with advanced renal cell carcinoma, a form of kidney cancer, who have already had anti-angiogenic therapy are treated with nivolumab.

4. It is used to treat patients with classical Hodgkin lymphoma who have relapsed or are resistant to prior treatments.

5. Nivolumab is used to treat advanced head and neck squamous cell carcinoma that has gotten worse after receiving platinum-based chemotherapy.

6. Urothelial Carcinoma: Following platinum-based chemotherapy, it is used to treat locally advanced or metastatic urothelial carcinoma, a kind of bladder cancer.

7. Nivolumab is used to treat colorectal cancer in people who have already had chemotherapy and who have certain genetic abnormalities.

8. Hepatocellular Carcinoma: In individuals who have already taken sorafenib, it is used to treat advanced hepatocellular carcinoma, a kind of liver cancer.

Injection-related Side Effects of Nivolumab:

1. Nivolumab can have adverse effects on the immune system, including exhaustion, rashes, diarrhoea, and inflammation of many organs, including the liver (hepatitis) and the lungs (pneumonitis).

2. Infusion Reactions: During or after the injection, some individuals may develop infusion reactions such as fever, chills, and shortness of breath.

3. Increased Risk of Infections: Nivolumab's effects on the immune system could make infections more likely.

4. Thyroid Disorders: It has the potential to lead to thyroid conditions including hypo- or hyperthyroidism.

5. Nivolumab may alter the results of blood tests that measure liver function and blood cell counts.

6. Gastrointestinal problems, including nausea, vomiting, and discomfort in the abdomen.

7. Skin Reactions: Some people may develop blisters or itchy skin as a result of their skin reactions.

8. Rarely, neurological side effects including disorientation or muscle weakness may manifest.

While having Nivolumab Injection, patients should be closely watched by their medical professionals, and any worrying symptoms or side effects should be reported right once to ensure proper management. Always use this drug under the guidance of a qualified oncologist or immunotherapy specialist. Nivolumab has proven to be effective in treating a variety of malignancies, but its use must be carefully assessed while taking into account the patient's unique circumstances and medical background. 

Product details 

Package Type




Dose Strength

10 mg/ml

Packaging Size

10 mg/ml

Prescription/Non prescription



Bristal Myers Squibb




Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Anti Cancer Drugs' category

"Accepting orders in bulk order quantity".
trade india member
Developed and Managed by Infocom Network Private Limited.